BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19073395)

  • 41. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 42. [Long-term treatment of chronic bronchitis with ambroxol].
    Schöpp W
    ZFA (Stuttgart); 1981 Sep; 57(26):1778-86. PubMed ID: 7303838
    [No Abstract]   [Full Text] [Related]  

  • 43. Ambroxol in the 21st century: pharmacological and clinical update.
    Malerba M; Ragnoli B
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1119-29. PubMed ID: 18680446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Sov Med; 1988; (5):69-72. PubMed ID: 3062806
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute sore throat and bronchitis. How effective are antibiotics?
    Mant A
    Aust Fam Physician; 2000 Sep; 29(9):860, 879. PubMed ID: 11008390
    [No Abstract]   [Full Text] [Related]  

  • 47. [Acute bronchitis: when are antibiotics, and when is symptomatic treatment indicated?].
    Gillissen A; Gessner C; Hammerschmidt S; Hoheisel G; Wirtz H
    MMW Fortschr Med; 2006 Jan; 148(1-2):26-8. PubMed ID: 16610409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ambroxol and simple chronic bronchitis. Effects on subjective symptoms and ventilatory function.
    Ericsson CH; Juhasz J; Jönsson E; Mossberg B
    Respiration; 1987; 51 Suppl 1():33-6. PubMed ID: 3299565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of halotherapy on free radical oxidation in patients with chronic bronchitis].
    Farkhutdinov UR; Abdrakhmanova LM; Farkhutdinov RR
    Klin Med (Mosk); 2000; 78(12):37-40. PubMed ID: 11210350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [To seize the evil by the roots. Zulu medicine improves cough, sore throat and common cold].
    MMW Fortschr Med; 2003 Dec; 145(49):56. PubMed ID: 14963996
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
    Brückner O; Trautmann M
    J Chemother; 1989 Jul; 1(4 Suppl):782-3. PubMed ID: 16312637
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ambroxol in the prevention of chronic bronchitis reactivation].
    Marcatili S; Zavattini G
    Arch Monaldi Mal Torace; 1989; 44(4-6):795. PubMed ID: 2577797
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhaled muscarinic antagonists for COPD--does an anti-inflammatory mechanism really play a role?
    Trevethick M; Clarke N; Strawbridge M; Yeadon M
    Curr Opin Pharmacol; 2009 Jun; 9(3):250-5. PubMed ID: 19286423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of large volume lavage of ambroxol hydrochloride on patients with pneumoconiosis combined with chronic bronchitis].
    Dai HS
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):565-6. PubMed ID: 17997898
    [No Abstract]   [Full Text] [Related]  

  • 55. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis.
    Sousa R; Lakha DR; Brette S; Hitier S
    Pulm Ther; 2019 Dec; 5(2):201-211. PubMed ID: 32026411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.
    Mroz RM; Holownia A; Chyczewska E; Braszko JJ
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erdosteine for COPD exacerbations.
    Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The traditional herbal medicine Hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease.
    Shinozuka N; Tatsumi K; Nakamura A; Terada J; Kuriyama T
    J Am Geriatr Soc; 2007 Feb; 55(2):313-4. PubMed ID: 17302677
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical trial of guacetisal in aged subjects with inflammatory diseases of the respiratory tract].
    Vizioli A; Zamperini D; Ursaia G
    Clin Ter; 1982 Dec; 103(5):527-33. PubMed ID: 6761043
    [No Abstract]   [Full Text] [Related]  

  • 60. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.